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Background: Malaria is a major mosquito-borne public health problem in Thailand with varied haematological
consequences. The study sought to elucidate the haematological changes in people who suspected malaria
infection and their possible predictive values of malaria infection.
Methods: Haematological parameters of 4,985 patients, including 703 malaria-infected and 4,282 non-malaria
infected, who admitted at Phop Phra Hospital, Tak Province, an area of malaria endemic transmission in Thailand
during 2009 were evaluated.
Results: The following parameters were significantly lower in malaria-infected patients; red blood cells (RBCs)
count, haemoglobin (Hb), platelets count, white blood cells (WBCs) count, neutrophil, monocyte, lymphocyte and
eosinophil counts, while mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), Mean corpuscular
haemoglobin concentration (MCHC), neutrophil-lymphocyte ratio (NLR), and monocyte-lymphocyte ratio (MLR) were
higher in comparison to non-malaria infected patients. Patients with platelet counts < 150,000/uL were 31.8 times
(odds ratio) more likely to have a malaria infection. Thrombocytopenia was present in 84.9% of malaria-infected
patients and was independent of age, gender and nationality (P value < 0.0001).
Conclusion: Patients infected with malaria exhibited important changes in most of haematological parameters with
low platelet, WBCs, and lymphocyte counts being the most important predictors of malaria infection. When used in
combination with other clinical and microscopy methods, these parameters could improve malaria diagnosis and
treatment.
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Changes in haematological parameters are likely to be
influenced by any disease condition including endemic
diseases, such as malaria, that can affects health of man-
kind with various clinical presentations. Malaria is a
major cause of deaths in the tropical area of the world.
Two hundred and nineteen million cases were reported
worldwide in 2010 [1]. Haematological changes are some
of the most common complications in malaria and they
play a major role in malaria pathogenesis. These changes
involve the major cell types such as RBCs, leucocytes* Correspondence: manas.ko@wu.ac.th
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unless otherwise stated.and thrombocytes [2-5]. Malaria infected patients tended
to have significantly lower platelets, WBCs, lymphocytes,
eosinophils, RBCs and Hb level, while monocyte and
neutrophil counts were significantly higher in compari-
son to non-malaria infected patients [2-4,6-8]. One study
showed patients with higher WBCs count compared with
community controls [9]. The most common complication
during malaria infection is thrombocytopenia [6,10-12].
Persons with platelet counts < 150,000/μL were 12-15
times more likely to have malaria infection than persons
with platelet counts > 150,000/μL [6]. A previous study
found that the ratio of monocytes to lymphocytes corre-
lated with risk of clinical malaria during follow-up [5]. In
Thailand, about five million people are in the area of high
malaria transmission mostly in border between Thailandl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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nosis of malaria especially in these areas.
Fever and other signs and symptoms are known to be
sensitive measures of malaria infection but they lack spe-
cificity and positive predictive values especially in areas
where malaria is less prevalent [3,14] and it may be diffi-
cult to distinguish the sign and symptom of disease from
other viral or bacterial infections [15]. Typically, micro-
scopic slide examination of peripheral blood remains the
most widely used test and is the gold standard for detect-
ing malaria infection [16]. However, due to it requires
technical expertise and is time-consuming in smear exam-
inations. Haematological changes during malaria infection,
such as thrombocytopenia and leucocytosis or leucopenia
are well recognized. Diagnostic value of these haemato-
logical alterations may be easily obtained and useful in
people living in malaria endemic areas.
Phop Phra is a district (Amphoe) in the southwestern
part of Tak Province, northern Thailand. It is in part of
the Thailand-Myanmar border and is the most common
destination for ethnic minorities from Myanmar who
migrate into Thailand for agricultural work. This prov-
ince has the highest number of malaria cases for 10 con-
secutive years. The present study aim to examine the
occurrences of haematological changes and their diagnos-
tic values in people infected with malaria in Phop Phra
Hospital. Haematological parameters including WBCs,
RBCs, platelets, red cell distribution width (RDW), MCV,
MCH, MCHC, and Hb level of people infected with mal-
aria were compared with uninfected people.
Methods
Data collection used in this study was approved by The
Phob Phra Hospital and The Ethical Clearance Commit-
tee on Human Rights Related to Researches Involving
Human Subjects of Walailak University. The data were
collected from the Medical Technology Laboratory Unit,
Phob Phra Hospital, Tak Province during January to
December 2009. Laboratory records of people suspected
with malaria infection such as fever, other signs and symp-
toms as medical doctor recommended were reviewed.
Four thousand nine hundred and eighty five patients with
full data recorded were included in this analysis. This
included 703 malaria and 4,282 non-malaria cases. The
data were retrieved from the venous blood sample
drawn into EDTA tubes for preparation of the thick
and thin smears and automated for determination of
Complete Blood Counts (CBCs). Blood counts were per-
formed using BC-5200 Haematology Analyzer (Mindray,
Nanshan, Shenzhen, China). The Analyzer provided data
on WBCs, RBCs, Hb level, platelet counts, MCV, MCH,
MCHC, RDW and five part differentials. The Haematol-
ogy Analyzer have an internal quality control (IQC) two-
times daily (First time in the morning before runningsample and second time in the afternoon) and also exter-
nal quality control (EQC) three times per year with De-
partment of Medical sciences. Blood slides were prepared
and stained with Giemsa. Microscopic abnormality of
blood in smear and presence or absence of malaria were
determined, the species and the number of asexual para-
sites. Data analysis was performed using SPSS ver. 11.5
(SPSS Inc., Chicago, IL, USA). Normally distributed of
continuous data were determined using The Kolmogorov-
Smirnov Test. Comparing between 3 groups of continuous
data was using a One-way ANOVA, whereas data not
conforming to normal distribution were compared by a
Kruskal-Wallis Test. Categorical data were compared
using Pearson Chi-Square Test. Association between two
continuous data was assessed by Pearson Correlation,
whereas data not conforming to normal distribution were
compared by Spearman’s rank correlation. Diagnostic
accuracy of haematological parameters was measured by
calculating sensitivity, specificity, predictive values and
odds ratios and 95% confidence intervals.
Results
Four thousand nine hundred and eighty five patients
were included in this study. The median age was 26
years (18-40) and 52.4% were males. Seven hundred and
three (n = 4,985) of the subjects had malaria infection
confirmed by microscopy while the remaining were non-
infection and were used as controls. In malaria-infected
patients, three hundred and fifty-two (50.1%) had Plas-
modium falciparum infection, whereas three hundred
and fifty-one (49.9%) had Plasmodium vivax infection.
There were significant differences between age, gender,
and nationality of patients with group of patients
(P value < 0.0001). Malaria positive patients were Burma
50.5%, followed by Thai 49.2% and other nationalities
0.3%, respectively (Table 1).
The median values of haematological parameters
of falciparum malaria, vivax malaria and non-malaria
infected group were compared using Kruskal-Wallis
Test due to non-parametric distribution of data. Median
values of RBCs, platelets, WBCs, and all absolute leukocyte
components counts were significantly lower in patients
with falciparum malaria compared to those with vivax mal-
aria and non-malaria infected groups. Conversely, median
of MCV, MCH, MCHC, NL ratio, and ML ratio were sig-
nificantly higher in falciparum malaria than those with
vivax malaria and non-malaria infected groups. A median
value of Hb was lower in patients with falciparum malaria
compared to those with vivax malaria and non-malaria in-
fected groups. Monocyte and eosinophil counts were
higher in patients with vivax malaria compared to those
with falciparum malaria and non-malaria infected groups.
There was no significant difference in median of RDW be-
tween three groups (Table 2).
Table 1 General characteristics
Plasmodium falciparum Plasmodium vivax Non-malaria P value
n = 352 n = 351 n = 4,282
Demographic
Age, medium (IQR) 26 (18-40) 23 (16-36) 16 (7-35) <0.0001*
Male/female, n (%) 215 (61.1)/137 (38.9) 209 (59.5)/142 (40.5) 2,190 (51.1)/2,092 (48.9) <0.0001**
Thai/Burma/Others, n (%) 160 (45.5)/192 (54.5) 186 (53)/165 (47) 3,230 (75.4)/1,052 (24.6) <0.0001**
*Comparison of 3 groups using The Kruskal Wallis Test, **Comparison of 3 groups using Pearson Chi-Square, IQR = interquartile range.
Kotepui et al. Malaria Journal 2014, 13:218 Page 3 of 7
http://www.malariajournal.com/content/13/1/218Red blood cells
Anaemia was defined as Hb level <11g/dl for both males
and females based on the WHO cutoff value. The median
of Hb in patients with falciparum malaria (11.7 g/dL) was
significantly lower than those with vivax malaria (11.9 g/dL)
and non-malaria (11.8 g/dL) groups (P value = 0.041). One
hundred and thirty-four (38.1%) of patients with falciparum
malaria; one hundred and fifteen (32.8%) of patients with
vivax malaria; one thousand three hundred and sixty-five
(31.9%) of patients with non-malaria groups had anaemia.
There was no significant association between status of mal-
aria infection and Hb cut-off (P value = 0.057). The median
of RBCs count was significantly lower in patients with
falciparum malaria (4.33 × 106/μL) than non-falciparum
malaria (4.45 × 106/μL) and non-malaria (4.63 × 106/μL)
groups (P value <0.0001). Patients with RBCs count less
than 4 × 106/μL was frequently seen in patients with falcip-
arum malaria (32.4%) compared to those with vivax malaria
(22.2%) and non-malaria (13.6%) groups (P value < 0.0001).
The median of MCV, MCH, and MCHC in both patient
with falciparum malaria and vivax malaria were significantlyTable 2 Haematological values in study population
Variable Plasmodium falciparum
Median (IQR)
RBC (x106/μL) 4.33 (3.78–4.8)
Haemoglobin (g/dL) 11.7 (9.8–13.1)
MCV (fL) 83.45 (78–3–87.7)
MCH (pg/cell) 27 (25–28.9)
MCHC (g/dL) 32.6 (31.6–33.4)
RDW (%) 12.8 (12.1–13.9)
Platelet (×103/μL) 72.5 (44–112)
WBC (×103/μL) 5.76 (4.52–7.99)
Neutrophil (×103/μL) 3.82 (2.77–5.18)
Lymphocyte (×103/μL) 1.28 (0.83–1.98)
Monocyte (×103/μL) 0.4 (0.25–0.61)
Eosinophil (×103/μL) 0.17 (0.73–0.31)
Basophil (×103/μL) 0.05 (0.04–0.06)
NL ratio 2.8 (2.81–4.88)
ML ratio 0.3 (0.3–0.43)
*Comparison of 3 groups using The Kruskal Wallis Test.higher than those with non-malaria group (P value < 0.001).
There was no significant association between status of
malaria infection and MCV> 100fL, MCH> 32pg/cell, and
MCHC >37g/dL cutoff value (P value > 0.05).
White blood cells
Leucopenia was defined as total WBCs count < 4,000/μL.
There was significant difference in total WBCs count
between three groups of patients (P value < 0.0001).
Leukocyte components were also significantly affected.
Neutrophil, lymphocyte, monocytes, eosinophil and
basophil counts were all significantly decreased in pa-
tients with falciparum malaria and vivax malaria as
compared to those with non-malaria group (P value <
0.0001). Neutrophil count > 2,800/μL was frequently
seen in the malaria-infected group (27.9%) than the non-
malaria infected group (19.5%) (P value < 0.0001). Lym-
phocytes < 800 /μL (lymphocytopenia) was frequently
seen in the malaria-infected group (20.1%) than the non-
infected group (4.6%) (P value < 0.0001). There were sig-
nificant differences in NL ratio and ML ratio betweenPlasmodium vivax Non-malaria P value*
Median (IQR) Median (IQR)
4.45 (4.04–4.88) 4.63 (4.25–5.02) <0.0001
11.9 (10.4–13) 11.8 (10.5–13.1) 0.041
82.2 (75–86.8) 81.7 (74.6–87.3) 0.001
26.9 (24–28.7) 26.3 (23.5–28.6) <0.0001
32.5 (31.7–33.3) 26.3 (23.5–28.6) <0.0001
12.8 (12.1–13.9) 12.7 (12–14) 0.967
89 (63–133) 242 (181–317) <0.0001
5.59 (4.48–7.18) 8.71 (6.17–12.4) <0.0001
3.44 (2.63–4.51) 5.08 (3.23–8.04) <0.0001
1.31 (0.9–1.89) 2.29 (1.55–3.41) <0.0001
0.4 (0.26–0.6) 0.57 (0.38–0.84) <0.0001
0.2 (0.08–0.37) 0.24 (0.12–0.47) <0.0001
0.06 (0.04–0.07) 0.08 (0.06–0.11) <0.0001
2.67 (1.69–4.22) 2.17 (1.2–3.95) <0.0001
0.29 (0.19–0.47) 0.24 (0.17–0.38) <0.0001
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(>2.8) was frequently seen in the malaria-infected group
than the non-infected group (P value < 0.0001). High ML
ratio (>0.25) was frequently seen in the malaria-infected
group than the non-infected group (P value < 0.0001).
Platelets
Thrombocytopenia was defined as platelets count <150,000/μL.
There were 597 patients with Thrombocytopenia (84.9%) in
the malaria-infected group. The median of platelet count in
patients with falciparum malaria (72.5 × 103/μL) and vivax
malaria (89 × 103/μL) were significantly lower than those
with non-malaria (242 × 103/μL) group (P value < 0.0001).
Thrombocytopenia was also associated with anaemia in
the malaria group (r = -0.107, P value = 0.004) and age
(r = -0.235, P value < 0.0001).
Diagnostic values of haematological parameters
Most of haematological parameters had good specificity
but lack of sensitivity to detect infection of malaria para-
site. However, low platelet count with platelet count
< 150,000/uL had high sensitivity (85%) and specificity
(85%) for diagnosis of malaria infection. This parameter
had better odds ratios. Patients with platelets count
< 150,000/uL were up to 31.8 (OR) times more likely
to have malaria infection than those with normal plate-
lets count (P value < 0.0001, OR = 31.8, CI = 25.1-39.7)
(Table 3). It could be predict that the association be-
tween thrombocytopenia and malaria infection would
not be significant following adjustment for age, gender,
and nationality of patients. Age, gender, and nationality,
correlated with risk of malaria infection (Table 4). How-
ever, adjusting for these demographic variables did notTable 3 Sensitivity, specificity, predictive value and odds rati
Malaria
Variable Sensitivity* (95% CI) Specificity* (95% CI)
RBC <4×106/μL 27 (24–31) 86 (85–87)
Hb < 11 g/dL 35 (32–39) 68 (67–70)
MCV >100 fL 1 (0.5–2) 98 (97–99)
MCH >32 pg/cell 3 (2–5) 97 (96–97)
MCHC >37 g/dL 2 (1–4) 98 (98–99)
Platelets <150,000/μL 85 (82–87) 85 (84–86)
WBCs <4,000/μL 17 (14–20) 94 (93–94)
Neutrophils <2,800/μL 35 (32–39) 69 (68–70)
Lymphocytes <800/μL 25 (23–28) 78 (77–79)
Monocytes <80/μL 3 (2–5) 98 (97–99)
Eosinophils <40/μL 27 (24–30) 71 (69–72)
Basophils <16/μL 89 (86–91) 12 (11–13)
NL ratio >2.8 49 (45–52) 61 (60–63)
ML ratio >0.25 58 (54–62) 54 (53–56)
PPV, positive predictive value; NPV, negative predictive value; PLR, positive likelihooconfound the association between thrombocytopenia
and malaria infection.
Discussion
This study confirms that haematological abnormalities
in malaria infection are common. Leucopenia was fre-
quently seen in the malaria-infected patients which was
confirmed by other studies that have demonstrated
leucopenia [6,15] and contrast with another study
that had demonstrate leucocytosis [3]. Neutrophil and
lymphocyte counts were the most important leukocytic
changes associated with malaria infection. The decrease
in lymphocyte counts associated with malaria observed
in this study may due to reflect redistribution of lym-
phocytes with sequestration in the spleen [6,17]. The de-
crease in neutrophil count associated with malaria
infection was in contrast with previous studies which
suggested that it might be activated neutrophil produc-
tion or release from the marrow or suppressed periph-
eral removal [3].
The observation of decreased monocytes counts in this
study was also in contrast with previous studies [3,18].
Mononuclear cells, which are activated by Plasmodium
during malarial infection, produce inflammatory cyto-
kines, such as tumor necrosis factor (TNF), interleukin-1
(IL1) and interleukin-6 (IL6). These cytokines stimulate
the hepatic synthesis of acute phase inflammatory pro-
teins, including CRP, which increase during malaria infec-
tion [17].
Anaemia is one of the most common complications
in malaria infection especially in younger children and
pregnant women in high transmission areas [19]. The
pathogenesis of anaemia during malaria infection is noto of the haematological parameters in diagnosis of
PPV* (95% CI) NPV* (95% CI) OR (95% CI) PLR NLR
25 (22–28) 88 (87–89) 2.4 (2–2.9) 2 0.8
15 (14–17) 87 (85–88) 1.2 (1–1.4) 1.1 0.9
10 (4–19) 86 (85–87) 0.7 (0.3–1.4) 0.7 1
13 (8–19) 86 (85–87) 0.9 (0.6–1.4) 0.9 1
18 (11–28) 86 (85–87) 1.4 (0.8–2.4) 1.4 1
48 (45–51) 97 (96–98) 31.8 (25.1–39.7) 5.6 0.2
30 (26–35) 88 (87–89) 3 (2.4–3.7) 2.7 0.9
16 (14–17) 87 (86–89) 1.2 (1.0–1.4) 1.1 0.9
17 (15–19) 86 (85–87) 1.4 (1.1–1.6) 1.2 1
19 (12–26) 86 (85–87) 1.4 (0.9–2.2) 1.4 1
13 (11–15) 86 (84–87) 0.9 (0.8–1) 0.9 1
14 (13–15) 86 (83–89) 1.0 (0.8–1.3) 1 1
17 (15–19) 88 (87–89) 1.5 (1.3–1.8) 1 0.8
17 (16–19) 89 (88–90) 1.7 (1.4–1.9) 1.3 0.8
d ratio; NLR, negative likelihood ratio, *Percent, OR, odds ratio.
Table 4 The association between risk of malaria and
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the parasite’s primary target is the red blood cell result-
ing in RBCs destruction, accelerated removal of both
parasitized and non-parasitized [20], bone marrow dys-
function [21] and the level of parasitemia [22]. This
study, reported a significant reduction of Hb level and
RBC count whereas MCV, MCH, and MCHC level in
patients infected with malaria were higher as compared
to non-malaria infected group. There are no evidence
relate to higher level of MCV, MCH, and MCHC
and pathogenesis of malaria infection but it has been
suggested that people with α+-thalassaemia protected
malaria infection by a direct interaction between the
parasite (Plasmodium falciparum) and the altered tha-
lassaemic erythrocyte, resulting in reduced parasite load
[23]. Most studies showed that α+-thalassaemia homozy-
gotes have better protection against severe malarial an-
aemia compared to heterozygotes [24,25]. Moreover,
patients with microcytosis and higher erythrocyte count
associated with α+-thalassaemia homozygosity had an
advantage against severe malarial anaemia during acute
infection with Plasmodium falciparum [26].
Platelet abnormalities in malaria are both qualitative
and quantitative change. In this study, platelet counts
were significantly reduced in malaria-infected people.
Thrombocytopenia occurred in 84.9% of malaria-
infected patients. These observations may imply that
thrombocytopenia may be a marker of Plasmodium in-
fection. The association of platelet count and malaria in-
fection has previously been described [3,7,18]. Patients
with thrombocytopenia were also likely to have an an-
aemia (r = -0.107, P value = 0.004) and correlate with age
(r = -0.235, P value < 0.0001) as previously reported
from a study in Kenya and Nigeria [3,8]. There were
various hypotheses about thrombocytopenia occurring
in malaria infection. Thrombocytopenia seems to occurthrough peripheral destruction [9], excessive removal of
platelets by spleen pooling [27,28] as well as platelet
consumption by the process of disseminated intravascu-
lar coagulopathy (DIC) [29]. Adequate or increased
number of megakaryocytes in the bone marrow affects
decreased thrombopoiesis an unlikely cause of thrombo-
cytopaenia in malaria [27]. Immune-mediated destruc-
tion of circulating platelets has been postulated as a
cause of thrombocytopenia seen in malaria infection.
Platelets have also been shown to mediate clumping of
P. falciparum infected erythrocytes [30]. This could lead
to pseudo thrombocytopenia. Malaria-infected patients
have elevated levels of specific immunoglobulinG (IgG)
in the blood which binds to platelet-bound malaria anti-
gens possibly leading to accelerated destruction of plate-
lets [10]. The previous study revealed that platelet
aggregation, which is the platelet clumps are falsely
counted as single platelet by the analyzers thus causing
pseudo-thrombocytopenia [3]. Additionally, during mal-
aria infection, endothelial activation was activated and
may contribute to loss of barrier function of the endo-
thelium and organ dysfunction. This process may use
platelets and their released proteins as an important regu-
lator of endothelial permeability resulting in thrombocyto-
paenia [31].
In this study, the sensitivity, specificity, positive pre-
dictive value, negative predictive value and diagnostic
accuracy for all haematoparameter were determined.
Among of those parameter, thrombocytopenia (platelet
counts < 150,000/μl) had the best sensitivity, specificity
and negative predictive value (85% sensitivity, 85% speci-
ficity, and 97% negative predictive value) which were
higher than the previous studies [11,12] while the posi-
tive predictive value was low (48%). The two most reli-
able haematological parameters for predicting malaria in
people from endemic areas were thrombocytopenia and
leucopenia. Patients with thrombocytopenia were 31.8
times more likely to have malaria infection than those
with normal platelets count. Thrombocytopenia and
leucopenia had sensitivity of 85% and 17%, specificity
85% and 94%, respectively to predict malaria infection.
Patients with leucopenia (WBCs <4,000/μL) were 2.7
times more likely to have malaria infection than those
with normal leucocytes count. High neutrophil counts,
leucopenia, and lymphopenia had good specificity but
lacked sensitivity to screening of malaria infection. The
monocytes to lymphocytes ratio (ML ratio) in this study
was high supported by the previous study that the ML
ratio, which was measured in peripheral blood was dir-
ectly correlates with risk of clinical malaria during
follow-up [5]. This may due to the major role of the
monocytes in the first time of innate immune response
by releasing IFNγ, to response to malaria infection [32].
When considered the neutrophil to lymphocytes ratio
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that the NL ratio was found to correlate with malaria
parasitaemia [4].
Limitations of this study included lack of previous
medical histories such as other diseases that may have
analysis bias such as Hb diseases, anaemia, bacteria or
virus infection, which could potentially affect the inter-
pretation of the results.
Conclusions
In conclusion, the association of haematological parame-
ters and a diagnosis of malaria infection among people
living in malaria endemic area was retrieved. The most
commonly changed parameters were platelet count, Hb,
RBC, MCV, MCH, MCHC, WBC, neutrophil, and
lymphocyte counts. Presence of thrombocytopenia in
people from endemic areas may be useful as supportive
diagnostic criteria for malaria in case with low level of
parasite number. Therefore, when used with other clin-
ical and microscopy parameters, it can significantly
improve malaria diagnosis and timely further treat for
malaria infection. The large sample size used in this
study gives this analysis power to detect differences be-
tween malaria infected and non-malaria infected people.
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